These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10979391)

  • 1. Osteoporosis prevention and treatment.
    Burger HG
    Med J Aust; 2000 Aug; 173(3):167-8. PubMed ID: 10979391
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of osteoporosis-related fractures with alendronate].
    Kopjar B; Bjørndal A
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):518-9. PubMed ID: 9520576
    [No Abstract]   [Full Text] [Related]  

  • 4. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.
    American Association of Clinical Endocrinologists Osteoporosis Task Force
    Endocr Pract; 2001; 7(4):293-312. PubMed ID: 11508261
    [No Abstract]   [Full Text] [Related]  

  • 5. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651
    [No Abstract]   [Full Text] [Related]  

  • 7. AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis.
    J Fla Med Assoc; 1996 Oct; 83(8):552-66. PubMed ID: 9160000
    [No Abstract]   [Full Text] [Related]  

  • 8. Medications for postmenopausal osteoporosis prevention.
    Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
    [No Abstract]   [Full Text] [Related]  

  • 9. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
    Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Medical Products Agency on prevention of osteoporosis: estrogen reduces the risk of fractures in certain women].
    Lakartidningen; 1994 Jan; 91(1-2):58-60. PubMed ID: 8289556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
    Eiken PA; Abrahamsen B
    Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of alendronate in the prevention and treatment of postmenopausal osteoporosis].
    Cheng ZQ; Yin W; Fan JY; Ma TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):306-9. PubMed ID: 12905641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progestins and osteoporosis. Does progestin contribute to the effectiveness of estrogen replacement therapy in menopause?].
    Lopes P
    Rev Fr Gynecol Obstet; 1995; 90(5-6):307-8. PubMed ID: 7569595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
    Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
    Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The waning effect of postmenopausal estrogen therapy on osteoporosis.
    Ettinger B; Grady D
    N Engl J Med; 1993 Oct; 329(16):1192-3. PubMed ID: 8377785
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.